心力衰竭中指导性医学治疗不耐受性的现实世界挑战:单中心前性队列研究
Junlong Chen1, Ruo'nan Xiao1, Lei Gao2
1Department of Cardiology, Chongqing Emergency Medical Center, Chongqing University Central Hospital, School of Medicine, Chongqing University, Chongqing, China; Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
International journal of cardiology
|May 13, 2025
概括
针对心力衰竭 (HF) 的指南导向医学治疗 (GDMT) 具有挑战性. 近一半的患者表现出不耐受性,主要是由于脏问题和低血压,影响治疗成功.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 指南导向医学疗法 (GDMT) 降低了心力衰竭 (HF) 的住院和死亡率.
- 优化GDMT的实施仍然是一个重大的临床挑战.
- 关于GDMT不耐受性的真实数据对于改善患者的治疗结果至关重要.
研究的目的:
- 评估急性心力衰竭患者GDMT不耐受症的现实挑战和原因.
- 为了比较启动GDMT的患者和不耐受GDMT的患者之间的结果.
- 为了确定与GDMT耐受性和坚持相关的因素.
主要方法:
- 选了263名急性HF患者,在出院前评估四倍GDMT启动.
- 根据启动成功,将患者分为GDMT不耐受组和GDMT组.
- 主要终点:在180天内第一次恶化HF事件或与HF相关的死亡的时间.
主要成果:
- 近50%的患者在出院时不能容忍四倍GDMT,主要是由于功能不全和低血压.
- 在出院时耐受GDMT的患者在180天的终点时更有可能接受四倍疗法 (92.4%对27.8%).
- 出院时启动GDMT降低了HF恶化的风险;更多的药物开始与更好的预后相关.
结论:
- 在现实世界中,GDMT的实施和剂量定位面临着重大障碍.
- 高水平的不耐受性,特别是来自功能衰竭和低血压,限制了四倍的GDMT使用.
- 早期启动GDMT,即使不是最大剂量,也会改善HF的预后.
相关概念视频
01:17Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
01:26Heart Failure Drugs: Inotropic Agents
469
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
469
01:22Heart Failure Drugs: Diuretics
306
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
306
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
347
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
347
01:22Heart Failure Drugs: β-Blockers
295
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
295
01:26Imbalances in Cardiac Output
1.2K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.2K